Dr. Stefanie Hauck

Stephanie Hauck heads the Metabolomics and Proteomics Core Unit at the Helmholtz Munich. She also has a strong background in retinal research and served on the Steering Committee of the Priority Program “Gene and Cell Based Therapies to Counteract Neuro-retinal Degeneration” (SPP 2127).